Skip to main content

News

  • Press Releases
  • Presentations & Publications
  • In The News
August 2, 2022
Boston Globe
Startup IDRx raises $122m to focus on combination drug treatments
Read More
August 2, 2022
Endpoints
New biotech from Alexis Borisy will test Merck KGaA, Blueprint cancer drug combo in bid to fulfill Gleevec promise
Read More
August 2, 2022
Biopharma Dive
IDRx, a new biotech startup, raises $122M to develop better cancer drug combinations
Read More
August 2, 2022
StatNews
Alexis Borisy, biotech’s ‘man of many hats,’ dons another
Read More
Intelligently Designed Precision Combinations to Transform Cancer Care
info@idrx.com
careers@idrx.com
media@idrx.com
  • Our Approach
  • Who We Are
  • Press Releases
© 2023 IDRx Inc. Privacy Policy. Terms of Use.